Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Rossello

Showing results (1-10 of 172) with videos related to

Pageof 18
Sort By:
European Heart Journal. Acute Cardiovascular Care|December 15, 2023
The P-value spectrum: from 'absence of evidence' to 'evidence of difference'Xavier Rossello
Journal of the American College of Cardiology|September 10, 2021
Lifetime Risk Estimation in Atherosclerotic Cardiovascular Disease: Where Inflammation Meets Lipoprotein(a)Xavier Rossello
Journal of Cardiac Failure|February 23, 2024
Safety Indicators in the STRONG-HF Trial From a Methodological PerspectiveXavier Rossello
European Heart Journal. Acute Cardiovascular Care|April 4, 2022
Trade-off between discrimination and calibration in risk scores: a perspective from the Sequential Organ Failure AssessmentXavier Rossello
European Heart Journal|April 12, 2026
Age, frailty, and outcomes in myocardial infarction: a new paradigm for an old conceptXavier Rossello
Lancet (London, England)|January 26, 2023
Cardiovascular risk assessment in survivors of cancerXavier Rossello
European Journal of Heart Failure|June 16, 2023
Globalization does not lead to homogenization in randomized controlled trials: Impact on sample size estimationXavier Rossello
Heart (British Cardiac Society)|March 26, 2025
Legacy effects in extension studies: standing the test of timeNatalia Fabin, Xavier Rossello
The Lancet. Diabetes & Endocrinology|July 24, 2021
Dapagliflozin in patients with COVID-19: truth or dareXavier Rossello, Francisca Caimari
The Lancet. Diabetes & Endocrinology|August 4, 2024
Sex differences in familial hypercholesterolaemiaXavier Rossello, Francisca Caimari
Pageof 18

Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
European Heart Journal. Acute Cardiovascular Care|December 15, 2023
The P-value spectrum: from 'absence of evidence' to 'evidence of difference'Xavier Rossello
Journal of the American College of Cardiology|September 10, 2021
Lifetime Risk Estimation in Atherosclerotic Cardiovascular Disease: Where Inflammation Meets Lipoprotein(a)Xavier Rossello
Journal of Cardiac Failure|February 23, 2024
Safety Indicators in the STRONG-HF Trial From a Methodological PerspectiveXavier Rossello
European Heart Journal. Acute Cardiovascular Care|April 4, 2022
Trade-off between discrimination and calibration in risk scores: a perspective from the Sequential Organ Failure AssessmentXavier Rossello
European Heart Journal|April 12, 2026
Age, frailty, and outcomes in myocardial infarction: a new paradigm for an old conceptXavier Rossello
Lancet (London, England)|January 26, 2023
Cardiovascular risk assessment in survivors of cancerXavier Rossello
European Journal of Heart Failure|June 16, 2023
Globalization does not lead to homogenization in randomized controlled trials: Impact on sample size estimationXavier Rossello
Heart (British Cardiac Society)|March 26, 2025
Legacy effects in extension studies: standing the test of timeNatalia Fabin, Xavier Rossello
The Lancet. Diabetes & Endocrinology|July 24, 2021
Dapagliflozin in patients with COVID-19: truth or dareXavier Rossello, Francisca Caimari
The Lancet. Diabetes & Endocrinology|August 4, 2024
Sex differences in familial hypercholesterolaemiaXavier Rossello, Francisca Caimari
Pageof 18